Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, April 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,531 followers.

シャペロンの文献２つです。 https://t.co/4ZVTXXid9r https://t.co/g5z6n98EME 私は英語が苦手なので自動翻訳しました。ざっくりと「ミガラスタットは患者の下痢を改善します」と自動翻訳でも内容はわかりましたよ。知識を得ることは良いかもです。 #ファブリシャペロン #ファブリー病 https://t.co/bwk8WDNLaZ

02 Jun 2022

Reply Repost Favourite

Open Access UCL Research: Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial https://t.co/xqTra3YeyG

04 Jun 2018

Reply Repost Favourite

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 ... https://t.co/0F5wz6ijQ7

03 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.